Chitin + anti-PD-1 combination treatment had an add-on effect in the 4T1-based model with a more significant reduction of CHI3L1 and CHI3L3 serum levels compared to untreated and anti-PD-1-treated tumor-bearing mice (Fig. 3D,E). This evidence concerns the gene PDCD1 and neoplasm.